United Therapeutics CEO Martine A. Rothblatt disposes of USD 3.94 million in common shares - UTHR News | RalliesUnited Therapeutics CEO Martine A. Rothblatt disposes of USD 3.94 million in common shares
U
UTHR• Insider transactions reported by United Therapeutics CEO
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported a 9,500-share common stock acquisition via option exercise on Sept. 9, 2026.
- Exercise price USD 117.76; shares held indirectly by a trust.
- The trust also sold 8,500 common shares on Sept. 9 at weighted-average prices from USD 493.81 to USD 509.
- Trust holdings ended at 324,443 shares following the reported transactions.
